KURA vs. NVNI
KURA (Kura Oncology, Inc.) and NVNI (Nvni Group Limited Ordinary Shares) are both stocks. KURA operates in Biotechnology (Healthcare), while NVNI operates in Software - Application (Technology). Over the past year, KURA returned 76.83% vs -66.61% for NVNI. At a 0.08 correlation, their price movements are largely independent.
Performance
KURA vs. NVNI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, KURA achieves a -0.10% return, which is significantly higher than NVNI's -63.22% return.
KURA
- 1D
- 0.19%
- 1M
- -7.73%
- YTD
- -0.10%
- 6M
- -3.80%
- 1Y
- 76.83%
- 3Y*
- -1.65%
- 5Y*
- -14.01%
- 10Y*
- 14.42%
NVNI
- 1D
- 2.94%
- 1M
- -18.78%
- YTD
- -63.22%
- 6M
- -67.19%
- 1Y
- -66.61%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
KURA vs. NVNI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
KURA Kura Oncology, Inc. | -0.10% | 19.29% | -39.43% | 63.97% |
NVNI Nvni Group Limited Ordinary Shares | -63.22% | -89.18% | 64.43% | -83.43% |
Correlation
The correlation between KURA and NVNI is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.07 |
Correlation (All Time) Calculated using the full available price history since Sep 29, 2023 | 0.08 |
Fundamentals
KURA:
$71.64M
NVNI:
R$0.00
KURA:
$67.71M
NVNI:
R$0.00
KURA:
-$304.14M
NVNI:
-R$26.99M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
KURA vs. NVNI — Risk / Return Rank
KURA
NVNI
KURA vs. NVNI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Kura Oncology, Inc. (KURA) and Nvni Group Limited Ordinary Shares (NVNI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| KURA | NVNI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.69 | ||
| Sortino ratioReturn per unit of downside risk | +1.78 | ||
| Omega ratioGain probability vs. loss probability | 1.23 | 1.04 | +0.20 |
| Calmar ratioReturn relative to maximum drawdown | 1.98 | -0.71 | +2.68 |
| Martin ratioReturn relative to average drawdown | 4.03 | -0.91 | +4.94 |
Loading charts...
Drawdowns
KURA vs. NVNI - Drawdown Comparison
The maximum KURA drawdown since its inception was -86.69%, smaller than the maximum NVNI drawdown of -99.31%. Use the drawdown chart below to compare losses from any high point for KURA and NVNI.
Loading charts...
Drawdown Indicators
| KURA | NVNI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -86.69% | -99.31% | +12.62% |
Max Drawdown (1Y)Largest decline over 1 year | -39.04% | -94.45% | +55.41% |
Max Drawdown (3Y)Largest decline over 3 years | -76.46% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -76.46% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -86.69% | — | — |
Current DrawdownCurrent decline from peak | -75.06% | -99.17% | +24.11% |
Average DrawdownAverage peak-to-trough decline | -47.33% | -90.34% | +43.01% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 19.12% | 73.02% | -53.90% |
Volatility
KURA vs. NVNI - Volatility Comparison
The current volatility for Kura Oncology, Inc. (KURA) is 18.47%, while Nvni Group Limited Ordinary Shares (NVNI) has a volatility of 28.65%. This indicates that KURA experiences smaller price fluctuations and is considered to be less risky than NVNI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| KURA | NVNI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.47% | 28.65% | -10.18% |
Volatility (6M)Calculated over the trailing 6-month period | 41.41% | 89.31% | -47.90% |
Volatility (1Y)Calculated over the trailing 1-year period | 60.17% | 166.25% | -106.08% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 62.11% | 320.94% | -258.83% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 70.38% | 320.94% | -250.56% |
Dividends
KURA vs. NVNI - Dividend Comparison
Neither KURA nor NVNI has paid dividends to shareholders.
Financials
KURA vs. NVNI - Financials Comparison
This section allows you to compare key financial metrics between Kura Oncology, Inc. and Nvni Group Limited Ordinary Shares. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
KURA and NVNI have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NVNI has higher volatility (28.65%) compared to KURA (18.47%). In terms of maximum drawdown, KURA dropped -86.69% vs NVNI's -99.31%.
KURA currently has the higher Sharpe Ratio (1.28 vs -0.40), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for KURA and NVNI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer